The drug is the latest innovation in its class of heart-burn medicines, known as PDE5 inhibitors. These are mainly used for the treatment of angina and chest pain, but also to treat symptoms of painful intercourse. PDE5 is a type of enzyme that breaks down an ingredient, cyclic guanosine monophosphate, in the body. PDE5 is thought to help with heartburn by blocking the effects of nitric oxide, which is a molecule produced in the stomach lining. The use of PDE5 inhibitors is also linked to an increased risk of heart attack, stroke and other cardiovascular events, according to the study.
Researchers at the University of Glasgow recruited 2340 men between the ages of 18 and 40 who had experienced heartburn or acid regurgitation. The subjects were randomly assigned to receive either a placebo or a PDE5 inhibitor in combination with a placebo group. After an 8-week washout period, a further eight weeks of treatment was started for the PDE5 inhibitor group. The researchers then compared the results of the eight weeks of treatment with the placebo group to the four weeks of treatment with the PDE5 inhibitor. At the end of the eight weeks, there was a significant reduction in the number of heartburn-related deaths, as well as an increased risk of cardiovascular events, such as cardiovascular death and nonfatal myocardial infarction. PDE5 inhibitors are generally considered safe and effective in treating heartburn, according to a previous study.
The use of PDE5 inhibitors, such as Viagra, have been linked to a higher incidence of cardiovascular events, such as a heart attack, compared to placebo treatment. According to the study, the risk of cardiovascular events was 4.9 times that of placebo, while the risk of myocardial infarction was 2.6 times higher for the PDE5 inhibitor group. The authors warn that this is a matter of debate because of the increased risk of cardiovascular events associated with the use of PDE5 inhibitors.
VIDEOThe study was conducted by researchers from the University of Glasgow and the Department of Pharmacology and Molecular Pharmacology, University of Liverpool.
Researchers from the University of Glasgow recruited 2340 men between the ages of 18 and 40 who had experienced heartburn or acid regurgitation. The researchers then compared the results of the eight weeks of treatment with the placebo group to the four weeks of treatment with the PDE5 inhibitor group.
In the treatment of heartburn, a significant reduction in the number of heartburn-related deaths, as well as an increased risk of cardiovascular events was observed. The researchers also noted that PDE5 inhibitors may be beneficial in the treatment of angina and angina associated with heartburn. The researchers further reviewed the available evidence on the use of PDE5 inhibitors in the treatment of angina. According to the study, the risk of cardiovascular events was 4.9 times that of placebo.
Pulmonary artery pressure was measured before the treatment and at the end of the eight weeks of treatment. The researchers found a significant reduction in pulmonary arterial pressure (PAP), a measure of blood pressure, in the PDE5 inhibitor group. The researchers also noted that the PAP increased significantly at the end of the eight weeks of treatment with the PDE5 inhibitor group. This increase in blood pressure was associated with an increase in the incidence of myocardial infarction. Pulmonary artery pressure should be considered an index of the effectiveness of a PDE5 inhibitor in the treatment of heartburn.
The authors add, “Based on our findings, it is evident that the use of PDE5 inhibitors is associated with an increased risk of developing cardiovascular events, such as a heart attack, stroke and myocardial infarction.”
The study was sponsored by Pfizer. The companies involved in the study are Pfizer, Aurobindo Pharma Ltd, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim Pharmaceuticals and Sandoz. Pfizer is an affiliate of Pfizer Consumer Healthcare, and the companies involved in the study are Pfizer Consumer Healthcare Ltd, Teva Pharmaceutical Industries Ltd and Sandoz. Pfizer was not involved in the study.
In addition, Pfizer’s patent on the drug expired in 2017 and the drug was no longer available as an online pharmacy.
IMPORTANT NOTICE: Please be aware, prior to sale, you are advised to have a short phone call consultation with our Pharmacist. Automatic purchase consents the Pharmacist to give you a quick call.
Viagra Connect is available without a Prescription but requires a brief consultation with the Pharmacist. It is available in a 4 pack or an 8 pack. Viagra Connect contains Sildenafil 50mg which works by relaxing the penis blood vessels, allowing blood to flow when you get aroused causing erections and potency. Viagra Connect will only help men become erect if you are aroused. Only for adult use, men 18 years plus.
How to be taken:
VIAGRA CONNECT is not to be taken if:
Please read instructions carefully provided.
Viagra Connect is a fast acting drug for erectile dysfunction which can last up to 4 hours and takes effect within 30 minutes after administration.
Sildenafil Citrate 50 mg Tablets: This tablet is specifically formulated to treat the symptoms of erectile disfunction and is highly effective in treating it, the most common sexual disorder affecting men over the age of 40 years. Provides a solution to erectile dysfunction in men who suffer from impotence due to conditions such as heart disease or diabetes, or who have problems with their physical or mental health.
Viagra Connect ensures fast and effective results that last as long as 36 hours and come without side effects. It works by relaxing the blood vessels in the penis, allowing blood to flow into the phallus when you get sexually excited and causing the desired stiffness.
IMPORTANT NOTICE: We require you to have a short phone call consultation with the Pharmacist. The Pharmacist is able to give you a quick call and we can give you a quick call or get in touch with some of the largest pharmaceutical companies in the market.Men 18 years + can use Viagra Connect for the treatment of erectile dysfunction. It helps men’s sexual health toImprove sexual health and Confidential checkout is required for all medicines sold.
Patientarantsurprisingly-advice-trusted worldwide – effective treatment of erectile dysfunctionVIAGRA CONNECT is a trusted and effective treatment for erectile dysfunction
VIAGRA CONNECT is a tablet for the treatment of erectile dysfunctionProduct detailsDelivery and pricing: We offer a fast and discreet delivery method that is convenient to all users of ED medicines.Men in the UK will soon be able to buy Viagra over the counter for the first time after the erectile dysfunction drug was reclassified.
Those aged 18 and over will no longer need to see a GP for a prescription after the Medicines and Healthcare products Regulatory Agency (MHRA) announced that it is changing the status of Viagra Connect tablets so they can be sold in pharmacies following a conversation with a pharmacist.
US pharmaceutical company Pfizer said it is working on plans to launch the non-prescription version of the medicine in the UK in the spring of 2018. A four-pack of the sildenafil tablets will cost around £19.99 and an eight-pack £34.99. Men who buy it will be advised that they can take a 50 mg tablet an hour before having sex, but should not use more than one pill a day. Sildenafil is already available on NHS prescription free of charge.
The decision to reclassify the drug follows a public consultation, the MHRA said. Pharmacists will be able to determine whether treatment is appropriate for the patient and can give advice on erectile dysfunction, usage of the medicine, potential side effects and assess if further consultation with a general practitioner is required.
“The move to make Viagra Connect more widely accessible will encourage men to seek help within the healthcare system and increase awareness of erectile dysfunction.”
Mick Foy, Medicines and Healthcare products Regulatory Agency
But some men, including those with severe heart problems, those at high risk of heart problems, liver failure, kidney failure or those taking certain “interacting medicines”, will still need to be prescribed the drug under the supervision of a doctor.
It is hoped that making the drug more widely available will mean than men who may have not previously sought help will be more likely to do so. Health officials also hope the move will also help steer people away from buying drugs websites operating illegally.
The MHRA said that erectile dysfunction medicines are a “popular target” for criminals selling unlicensed and counterfeit medicines, over the past five years the Agency has seized more than £50m of unlicensed and counterfeit erectile dysfunction medicines.
“This decision is good news for men’s health,” said Mick Foy, MHRA’s group manager in vigilance and risk management of medicines. “The move to make Viagra Connect more widely accessible will encourage men to seek help within the healthcare system and increase awareness of erectile dysfunction.
“Erectile dysfunction can be a debilitating condition, so it’s important men feel they have fast access to quality and legitimate care, and do not feel they need to turn to counterfeit online supplies which could have potentially serious side effects.”
Dr Berkeley Phillips, UK medical director at Pfizer, said: “The availability of Viagra Connect in pharmacies from next year will offer men who are eligible for the product a new and convenient way to access sildenafil, a commonly prescribed treatment for erectile dysfunction.
“We understand some men may avoid seeking support and treatment for this condition, so we believe giving them the option to talk to a pharmacist and buy Viagra Connect could be a real step forward in encouraging more men into the healthcare system.
“As erectile dysfunction may be a sign of an underlying condition such as diabetes, high blood pressure, or heart disease, there could also be a wider benefit to public health in the long term. We hope that this forthcoming new opportunity to purchase a genuine treatment via pharmacy will also reduce the likelihood of men turning to potentially ineffective and dangerous counterfeits from illicit sources.”
Is it safe to buy Viagra Connect over the counterThe country's president, Witczal Theirlaw, will arrive in the South at the beginning of October to take up his doctor’s name and security clearance. He is to stage a media address in the region in the future, alongside speaking talent and professional)] in his South African capital, as a special guest.
A special address will be held by the president at the State House, with The Sun’s Tim Law announcing he’ll serve as the country’s new president at the state house. The website offers a range of news, photos and videos including.
Viagra is a brand name for the generic medication sildenafil, the same active ingredient found in Viagra. It is a brand-name medication prescribed by a doctor to treat erectile dysfunction in men. Viagra has a long history in the pharmaceutical industry and was the first medicine to be approved by the FDA for the treatment of erectile dysfunction.
The generic version is available as a tablet, and the active ingredient in Viagra is sildenafil. It belongs to a class of medications called phosphodiesterase type 5 (PDE5) inhibitors. These drugs work by increasing blood flow to the penis, helping to achieve and maintain an erection.
Viagra works by relaxing the smooth muscles in the walls of blood vessels in the penis. This helps to improve blood flow to the penis, allowing for an erection when sexually stimulated. This process can happen quickly, usually within 30 minutes of taking the pill.
The effectiveness of Viagra is up to 80% in studies of men who take the medication. It is most effective when taken as prescribed by a doctor.
Viagra is a prescription medication and can be taken by men under the supervision of a doctor. It is generally safe to take as prescribed by a doctor. However, if you are not sure if you are taking any other medications, talk to your doctor.
If you miss a dose of Viagra, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take a double dose.